Thyroid dysfunction and serum lipids: a community-based study

被引:107
作者
Walsh, JP
Bremner, AP
Bulsara, MK
O'Leary, P
Leedman, PJ
Feddema, P
Michelangeli, V
机构
[1] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia
[2] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia
[3] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia
[4] Dept Hlth, Genom Directorate, Perth, WA, Australia
[5] Univ Western Australia, Sch Womens & Infants Hlth, Nedlands, WA 6009, Australia
[6] Western Australian Inst Med Res, UWA Ctr Med Res, Lab Canc Med, Perth, WA, Australia
[7] Royal Perth Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia
[8] Biomediq DPC, Doncaster, Vic, Australia
关键词
D O I
10.1111/j.1365-2265.2005.02399.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective It is uncertain whether subclinical hypothyroidism (SCH) is associated with hypercholesterolaemia, particularly in subjects with SCH and serum TSH <= 10 mU/l. Design, patients and measurements Cross-sectional study of 2108 participants in a 1981 community health survey in Busselton, Western Australia. Serum total cholesterol and triglycerides were measured in all subjects and high density lipoprotein cholesterol (HDL-C) measured (and low density lipoprotein cholesterol (LDL-C) calculated) in a subgroup of 631 subjects at the time of the survey. In 2001, TSH and free T4 concentrations were measured on archived sera stored at -70 degrees C. Serum lipid concentrations in subjects with thyroid dysfunction and euthyroid subjects were compared using linear regression models. Results In the group as a whole, serum total cholesterol was higher in subjects with SCH (N = 119) than in euthyroid subjects (N = 1906) (mean +/- SD 6.3 +/- 1.3 mmol/l vs. 5.8 +/- 1.2 mmol/l, P < 0.001 unadjusted, P = 0.061 adjusted for age, age(2) and sex). Serum total cholesterol was similarly elevated in subjects with SCH and TSH <= 10 mU/l (N = 89) (6.3 +/- 1.3 mmol/l, P < 0.001 unadjusted, P = 0.055 adjusted for age, age(2) and sex). In the subgroup analysis, LDL-C was higher in subjects with SCH (N = 30) than in euthyroid subjects (N = 580) (4.1 +/- 1.2 mmol/l vs. 3.5 +/- 1.0 mmol/l, P < 0.01 unadjusted, P = 0.024 adjusted for age, age(2) and sex). LDL-C was significantly increased in subjects with SCH and TSH <= 10 mU/l (N = 23) (4.3 +/- 1.3 mmol/l, P < 0.001 unadjusted, P = 0.002 adjusted for age, age(2) and sex). Conclusion SCH is associated with increased serum LDL-C concentrations, which is significant after adjustment for age, age(2) and sex.
引用
收藏
页码:670 / 675
页数:6
相关论文
共 42 条
  • [31] DISTURBED LIPID-METABOLISM IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM - EFFECT OF L-THYROXINE THERAPY
    MIURA, S
    IITAKA, M
    YOSHIMURA, H
    KITAHAMA, S
    FUKASAWA, N
    KAWAKAMI, Y
    SAKURAI, S
    URABE, M
    SAKATSUME, Y
    ITO, K
    ISHII, J
    [J]. INTERNAL MEDICINE, 1994, 33 (07) : 413 - 417
  • [32] Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism:: A double-blind, placebo-controlled study
    Monzani, F
    Caraccio, N
    Kozàkowà, M
    Dardano, A
    Vittone, F
    Virdis, A
    Taddei, S
    Palombo, C
    Ferrannini, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) : 2099 - 2106
  • [33] Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease
    Müller, B
    Tsakiris, DA
    Roth, CB
    Guglielmetti, M
    Staub, JJ
    Marbet, GA
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (02) : 131 - 137
  • [34] A DOUBLE-BLIND CROSSOVER 12-MONTH STUDY OF L-THYROXINE TREATMENT OF WOMEN WITH SUBCLINICAL HYPOTHYROIDISM
    NYSTROM, E
    CAIDAHL, K
    FAGER, G
    WIKKELSO, C
    LUNDBERG, PA
    LINDSTEDT, G
    [J]. CLINICAL ENDOCRINOLOGY, 1988, 29 (01) : 63 - 75
  • [35] HYPERLIPIDEMIA IN PATIENTS WITH PRIMARY AND SECONDARY HYPOTHYROIDISM
    OBRIEN, T
    DINNEEN, SF
    OBRIEN, PC
    PALUMBO, PJ
    [J]. MAYO CLINIC PROCEEDINGS, 1993, 68 (09) : 860 - 866
  • [36] CIRCULATING LIPIDS AND MINOR ABNORMALITIES OF THYROID-FUNCTION
    PARLE, JV
    FRANKLYN, JA
    CROSS, KW
    JONES, SR
    SHEPPARD, MC
    [J]. CLINICAL ENDOCRINOLOGY, 1992, 37 (05) : 411 - 414
  • [37] Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants
    Pirich, C
    Müllner, M
    Sinzinger, H
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (06) : 623 - 629
  • [38] SPECTRUM OF SUBCLINICAL AND OVERT HYPOTHYROIDISM - EFFECT ON THYROTROPIN, PROLACTIN, AND THYROID RESERVE, AND METABOLIC IMPACT ON PERIPHERAL TARGET TISSUES
    STAUB, JJ
    ALTHAUS, BU
    ENGLER, H
    RYFF, AS
    TRABUCCO, P
    MARQUARDT, K
    BURCKHARDT, D
    GIRARD, J
    WEINTRAUB, BD
    [J]. AMERICAN JOURNAL OF MEDICINE, 1992, 92 (06) : 631 - 642
  • [39] Subclinical thyroid disease - Scientific review and guidelines for diagnosis and management
    Surks, MI
    Ortiz, E
    Daniels, GH
    Sawin, CT
    Col, NF
    Cobin, RH
    Franklyn, JA
    Hershman, JM
    Burman, KD
    Denke, MA
    Gorman, C
    Cooper, RS
    Weissman, NJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (02): : 228 - 238
  • [40] TURNBRIDGE WMG, 1977, CLIN ENDOCRINOL OXF, V7, P495